NCI Small Grants Program for Cancer Research (NCI Omnibus R03)

PAR-14-007
NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
Department of Health and Human Services
National Institutes of Healthall-of-us-v-cancer

Section I. Funding Opportunity Description

This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), supports discrete, well-defined projects in any area of cancer research using the NIH R03 small grant mechanism.

The NIH R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in 2 years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following:

  • Pilot or feasibility studies;
  • Secondary analysis of existing data;
  • Small, self-contained research projects;
  • Development of research methodology; and
  • Development of new research technology.
Specific Research Objectives

All areas of cancer research relevant to the mission of the NCI are appropriate for projects submitted in response to this FOA (for a list of extramural research funding programs at the NCI, go to http://www.cancer.gov/researchandfunding/extramural). Projects proposed in response to this FOA may involve basic, translational, clinical, and/or population research related to cancer. Examples of relevant areas include but are not limited to studies of: cancer biology; cancer control; cancer diagnosis; cancer disparities; cancer prevention; and cancer treatment.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-007
Funding Opportunity Title: NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 21, 2013
Last Updated Date: Aug 26, 2016
Original Closing Date for Applications: Jan 05, 2017  
Current Closing Date for Applications: Aug 26, 2016  
Archive Date: Sep 26, 2016
Estimated Total Program Funding:  
Award Ceiling: $50,000
Award Floor:  

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
State governments
Public housing authorities/Indian housing authorities
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Public and State controlled institutions of higher education
Private institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), of the National Institutes of Health (NIH) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-007.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)

PAR-16-284
Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)
Department of Health and Human Services
National Institutes of Healthcancer-682x1024

Section I. Funding Opportunity Description

The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation’s biomedical, behavioral, and clinical research needs. In addition to this opportunity, NIH Institutes and Centers (ICs) support a variety of other mentored career development programs designed to foster the transition of new investigators to research independence. These other programs may be more suitable for particular candidates.  NIH also supports non-mentored career development programs for independent investigators. More information about Career programs may be found at the NIH Extramural Training Mechanisms website.

The objectives of the NIH Academic Career Award (K07) are to increase the pool of individuals with academic and research expertise in a specific area of biomedical research and to enhance the educational or research capacity at the grantee institution. The K07 Development Award supports more junior investigators who are interested in developing academic and research expertise in a particular health-related field, as a way to increase the overall pool of individuals capable of research or teaching in the identified area. Research, teaching, and leadership skills are to be learned during the tenure of the award. Curriculum building skills are encouraged.

The objective of the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) is to increase the pool of individuals with academic and research expertise in these specific areas of biomedical research. The award provides salary and mentored research support for a sustained period of “protected time” to junior investigators who are interested in developing academic and research expertise in these particular health-related fields. Candidates must have no more than 8 years of research experience after the terminal doctoral degree at the time of the initial or the subsequent resubmission application; clinical training is not included within this 8-year limit. The expectation is that, through this sustained period of research career development and training under the guidance of an experienced mentor in the biomedical, behavioral, or clinical sciences, awardees will launch fully independent research careers and become competitive for new research project grant (e.g., R01) funding.

For the purpose of this funding opportunity, cancer control research is defined as “basic and applied research in the behavioral sciences that independently or in combination with biomedical approaches reduces cancer risk, incidence, morbidity, and mortality across the lifespan and over the entire process of carcinogenesis from primary behavioral prevention in youth, to screening, treatment, and survivorship” (Report of the NCI Cancer Control Progress Review Group, 1997-1998 ).

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-284
Funding Opportunity Title: Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.398 — Cancer Research Manpower
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Posted Date: May 25, 2016
Last Updated Date: May 25, 2016
Original Closing Date for Applications: Jan 07, 2018  
Current Closing Date for Applications: Jan 07, 2018  
Archive Date: Feb 07, 2018
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants:
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Independent school districts
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) is to support the career development of junior investigators with research or health professional doctoral degrees who want to become cancer-focused academic researchers in cancer prevention, cancer control, or the behavioral or population sciences.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-284.html
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Emerging Questions in Cancer Systems Biology (U01)

PAR-16-131
Emerging Questions in Cancer Systems Biology (U01)
Department of Health and Human Services
National Institutes of HealthsymposiumISB

Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research projects addressing challenging cancer problems using systems biology approaches. In support of this goal, the National Cancer Institute (NCI) has initiated the Cancer Systems Biology Consortium (CSBC) through multiple FOAs. The CSBC network will consist of specialized U01 Research Projects (supported under this FOA), U54 CSBC Research Centers (supported under RFA-CA-15-014), and a U24 Coordinating Center (supported under RFA-CA-15-015).

CSBC Research Projects should address a well-defined, discrete, and circumscribed research question in cancer incorporating quantitative experimentation, analysis, modeling and validation, which are the hallmarks of systems biology. As part of the CSBC, investigators from the Research Projects will have the opportunity to share resources and expertise across the Consortium and participate in Consortium activities and annual meetings.

Background

Research strategies that can integrate across molecular, genetic, and cellular events are required to understand the multivariate nature of cancer and to predict tumor behaviors, efficient treatment opportunities, and, ultimately, patient outcome. Cancer systems biology approaches provide the iterative experimental and analytical toolkit necessary for addressing complex problems in cancer research. Through development of measurement technologies, generation of rich datasets, and employment of computational, mathematical, and algorithmic tools, cancer systems biologists have made important strides in describing cancers as integrated systems of genes, networks, and intercellular interactions. Cancer systems biology is uniquely poised to address various important and/or emerging questions in cancer research that would be difficult, if not impossible, to explore fully using other, less comprehensive approaches.

Along with general cancer-related topics such as the heterogeneous nature of tumors and the widely variable genetic underpinnings of cancer, there are a variety of emerging directions in cancer research that are particularly amenable to a systems approach: (a) decoding dynamic tumor-stroma and/or tumor-immune system interactions; (b) integrating chemical, molecular, structural, network, and localization information across temporal and spatial scales to understand tumor behavior; (c) understanding how individual cell states shape the behavior of tumors and tumor ecosystems; (d) determining how the microbiome affects tumor initiation, progression or treatment; (e) forward engineering of cancer systems through the convergence of synthetic biology and systems biology; (f) bridging the many cancer hierarchies; and (g) utilizing cancer systems biology predictions to inform clinical trial design.

In addition to addressing specific biological hypotheses, the continued success of cancer systems biology depends on the development of new methodologies to address complex and multivariate questions, including new theoretical, mathematical and computational techniques, multi-scale modeling approaches capable of integrating across scales from the molecular to the population level, and new biological tools and systems for informing and testing cancer systems biology generated hypotheses.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-131
Funding Opportunity Title: Emerging Questions in Cancer Systems Biology (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
Cost Sharing or Matching Requirement: No
Posted Date: Mar 11, 2016
Last Updated Date: Mar 11, 2016
Original Closing Date for Applications: Nov 23, 2018  
Current Closing Date for Applications: Nov 23, 2018  
Archive Date: Dec 24, 2018
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants:
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Special district governments
Public and State controlled institutions of higher education
County governments
City or township governments
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The National Cancer Institute (NCI) is sponsoring a new Cancer Systems Biology Consortium (CSBC) that includes U54 CSBC Research Centers (RFA-CA-15-014), a U24 CSBC Coordinating Center (RFA-CA-15-015) and, through this FOA, well-defined, discrete and circumscribed Research Projects addressing emerging problems in cancer. The CSBC initiative aims to address challenges in cancer research through the use of experimental biology or population science combined with in silico modeling, multi-dimensional data analysis, and systems engineering.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-131.html
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Health Promotion and Disease Prevention Centers: Special Interest Project Competitive Supplements (SIPS)

RFA-DP-16-006
Health Promotion and Disease Prevention Centers: Special Interest Project Competitive Supplements (SIPS)
Department of Health and Human Services
Centers for Disease Control and Prevention

Background and Purpose

The purpose of the Prevention Research Centers (PRC) program’s Special Interest Projects (SIPs) mechanism is to support
supplemental projects in health promotion and disease prevention research. A major focus of this supplemental funding program is
to design, test, and disseminate effective applied public health prevention research strategies.
The US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP) seeks competitive supplement cooperative agreement
applications for the Health Promotion and Disease Prevention Research Centers Program. This FOA aligns with the following
public health priorities:
1. Healthy People 2020 Objectives related to health promotion and disease prevention.
2. The National Prevention Strategy.
3. CDC’s Winnable Battles which cover health topic of reducing tobacco use.
4. The NCCDPHP Domains of (a) strategies to improve community-clinical linkages that support patient efforts to manage their
conditions or disease risk, (b) conduct surveillance to enhance prevention, and reduce premature morbidity and mortality due to
chronic diseases, (c) health systems interventions to improve the effective delivery and use of quality clinical and other
preventative services to prevent disease; detect disease early; reduce or eliminated risk factors; mitigate or manage complications;
and support patient self-management education, (d) defining and supporting evaluation and applied research activities to reduce
disparities in cancer rates among different population groups, (e) health system interventions to improve the effective delivery and
use of clinical and other preventive services, and (f) support environmental approaches that promote health and support and
reinforce healthful behaviors in worksites.

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-16-006
Funding Opportunity Title: Health Promotion and Disease Prevention Centers: Special Interest Project Competitive Supplements (SIPS)
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 8
CFDA Number(s): 93.135 — Centers for Research and Demonstration for Health Promotion and Disease Prevention
Cost Sharing or Matching Requirement: No
Posted Date: Dec 23, 2015
Creation Date: Dec 23, 2015
Original Closing Date for Applications: Feb 22, 2016  Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Feb 22, 2016   Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Mar 23, 2016
Estimated Total Program Funding: $3,375,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants:
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Competition is limited to Prevention Reseach Centers (PRCs) institutions funded under DP14-001. Special eligibility requirement(s) may apply to each SIP (see Section IX. Special Interest Project Description).

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: This RFA will provide supplemental funding to Prevention Research Centers (PRCs) to design, test, and disseminate effective applied public health prevention research strategies to include behavioral interventions, environmental or system-wide solutions, and strategies that address major causes of disease and disability. Research strategies align with public health priorities such as the Healthy 2020 topic areas: Cancer, Oral Health, and Workplace Health.
Link to Additional Information:
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Michael Brown MAB5@cdc.gov
Grants Policy

Examination of Survivorship Care Planning Efficacy and Impact (R01) and (R21)

PA-16-012
Examination of Survivorship Care Planning Efficacy and Impact (R01)
Department of Health and Human Services
National Institutes of Healthplan_beyond_cancer-slider

Specific Research Objectives

Applications are expected to assess whether care planning renders added benefits in terms of reducing morbidity, increasing adherence to follow-up guidelines, better self-management of late effects, appropriate utilization of follow-up care, and reduced cost.  The proposed research should also evaluate the pathways and processes through which such benefit is derived and clarify to whom such benefits accrue (survivors, clinicians, delivery systems, payers). Transdisciplinary approaches that link health services and health economics research with clinical, behavioral, and social science disciplines are encouraged. Studies documenting the organizational context and key processes through which successful care planning occurs are invited, including those that study how the generation and use of survivorship care plans intersects with processes of care delivery, inter-provider communication, patient-provider communication, and meaningful use of informatics. Studies linking care planning to use of electronic medical records, and exploring ways to harness electronic platforms, tools and applications are encouraged. Studies of how successful care planning initiatives are implemented in a variety of healthcare and community practice settings are encouraged. Studies may include family and caregiver outcomes in addition to survivor outcomes. Studies that will be considered for funding are limited to those that focus on individuals diagnosed with cancer at age 21 or older.

Research Applications are particularly encouraged to consider the following issues in the Research Strategy:

  • Inclusion of at least one survivor-level outcome (behavioral, physical and/or psychosocial morbidity) and at least one provider or system-level outcome (service use, time use, knowledge) related to care delivery or cost.
  • Studies assessing the impact of care planning or identifying effective models of care are expected to use comparative designs (randomized controlled trials, quasi-experimental, case-control, interrupted time series, or similar designs) that allow comparison of care planning strategies.
  • Adjunctive qualitative or quantitative observational approaches are encouraged in the context of the above designs.
  • Because the standard of care is not yet consistently established, investigators are expected to carefully document and describe the care planning protocol studied in all inquiries. Studies are encouraged to use care plans that include, but are not limited to, Institute of Medicine-recommended content for survivorship care plans.
  • Studies focused on the development and testing of instruments to evaluate survivorship care planning may use the R01 mechanism or the companion R21 mechanism, as appropriate.

Research areas of interest include, but are not limited, to:

  • What are the best constructs and outcomes for evaluating survivorship care planning and which metrics are best suited to measure these?
  • What is the impact of survivorship care planning on cancer survivors’ post-treatment psychosocial and physiologic morbidity?
  • What is the effect of survivorship care planning on adherence to screening recommendations, preventive behaviors, and self-management of late and long-term effects of cancer?
  • What is the optimal timing for delivery of survivorship care planning?
  • Does survivorship care planning decrease unnecessary health care resource utilization?
  • What are the differential costs associated with the generation and implementation of care plans versus usual care, and what value is added, if any?
  • How do care plans affect the number of patients seen/day, the length of patient visits, number of patient visits to oncology and/or primary care, information systems, and reimbursements?
  • Who should be involved, and how, in the development and delivery of care plans? What are the respective roles of oncology and primary care physicians, nurses, social workers, and other allied health professionals in the care planning process?
  • What systems, organizational and provider-level factors influence the generation, transmission, communication, usability, and ultimate consistent use of survivorship care plans?
  • What incentives and barriers affect adoption of survivorship care planning across diverse healthcare practice settings?
  • What economic strategies could encourage implementation of care planning?
  • Does provider participation in the development of care plans and the care planning process affect implementation of care planning?
  • How can electronic platforms, tools, and applications be harnessed to optimize patient knowledge, patient preparation, and/or care coordination in survivorship care planning?
  • What costs are associated with face-to-face vs. hybrid, automated, or wiki-supported approaches to survivorship care planning?

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-16-012
Funding Opportunity Title: Examination of Survivorship Care Planning Efficacy and Impact (R01)
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Posted Date: Oct 23, 2015
Creation Date: Oct 23, 2015
Original Closing Date for Applications: Jan 7, 2019  
Current Closing Date for Applications: Jan 7, 2019  
Archive Date: Feb 7, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants:
Independent school districts
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
City or township governments
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research evaluating the effect of care planning on self-management of late effects of cancer therapy; adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors’ health and psychosocial outcomes. How organizational-level factors influence the implementation of care planning and its associated costs is also of interest. Specifically, the FOA aims to stimulate research that will: 1) develop and test metrics for evaluating the impact of survivorship care planning; 2) evaluate the impact of survivorship care planning on cancer survivors’ morbidity, self-management and adherence to care recommendations, utilization of follow-up care; 3) evaluate effects of planning on systems outcomes, such as associated costs and impact on providers and organizations implementing the care planning; and 4) identify models and processes of care that promote effective survivorship care planning. The ultimate goal of this FOA is to generate a body of science that will inform the development and delivery of interventions that improve follow-up care for cancer survivors.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-16-012.html
Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster